University of Colorado, Anschutz Cancer Pavilion — Aurora, Colorado

Public research footprint of University of Colorado, Anschutz Cancer Pavilion, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Melanoma · Small Cell Lung Cancer Metastatic or Locally Advanced · Locally Advanced Neuroendocrine Prostate Cancer · Multifocal Motor Neuropathy (MMN)

Recently updated registry entries

NCT07227597 — A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People… (Recruiting)
NCT07080242 — Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung… (Recruiting)
NCT04700124 — Perioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) Versus Neoadjuvant… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of Colorado, Anschutz Cancer Pavilion?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.